PET imaging has grown over the past two decades to become a mainstay in the diagnosis and management of cancer patients. While oncology scans continue to comprise the majority of PET scans, new radiopharmaceuticals offer the promise of increasing the efficacy of PET imaging for cardiology and neurology.
IMV’s 2023 PET Imaging Market Summary Report monitors trends in PET scan utilization, the adoption of fixed PET scanners (e.g., PET-only, PET/CT, and PET/MR), the use of mobile PET services, purchase plans, and radiopharmaceutical use. Survey results are projected to the universe of facilities using PET, and the report addresses the PET unit market for 2022-2026.
Key Features
PET Scan Volume
PET Equipment Installed Base and Purchase Plans
Radiopharmaceuticals Utilization and Budgets
Site Operations Characteristics
This 2023 PET Imaging Market Summary Report summarizes the results from IMV Medical Information Division’s 2022 PET Census of hospital and non-hospital facilities performing PET imaging in the United States. The universe of PET sites for this study is defined as any location where PET scans are performed using a fixed PET-only, fixed PET/CT, fixed PET/MR, or a PET-only or PET/CT scanner provided by a mobile van service. The responses from the 386 PET imaging professionals have been projected to IMV’s identified universe of 2,445 hospitals and imaging/PET centers that perform PET imaging using fixed or mobile PET equipment.